These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 27035096

  • 1. Chemosensitizing effect of podophyllotoxin acetate on topoisomerase inhibitors leads to synergistic enhancement of lung cancer cell apoptosis.
    Hong WG, Cho JH, Hwang SG, Lee E, Lee J, Kim JI, Um HD, Park JK.
    Int J Oncol; 2016 Jun; 48(6):2265-76. PubMed ID: 27035096
    [Abstract] [Full Text] [Related]

  • 2. Podophyllotoxin acetate enhances γ-ionizing radiation-induced apoptotic cell death by stimulating the ROS/p38/caspase pathway.
    Choi JY, Cho HJ, Hwang SG, Kim WJ, Kim JI, Um HD, Park JK.
    Biomed Pharmacother; 2015 Mar; 70():111-8. PubMed ID: 25776488
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Luteolin acts as a radiosensitizer in non‑small cell lung cancer cells by enhancing apoptotic cell death through activation of a p38/ROS/caspase cascade.
    Cho HJ, Ahn KC, Choi JY, Hwang SG, Kim WJ, Um HD, Park JK.
    Int J Oncol; 2015 Mar; 46(3):1149-58. PubMed ID: 25586525
    [Abstract] [Full Text] [Related]

  • 8. Combination of 2-deoxy d-glucose and metformin for synergistic inhibition of non-small cell lung cancer: A reactive oxygen species and P-p38 mediated mechanism.
    Hou XB, Li TH, Ren ZP, Liu Y.
    Biomed Pharmacother; 2016 Dec; 84():1575-1584. PubMed ID: 27825799
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
    Honore S, Kamath K, Braguer D, Horwitz SB, Wilson L, Briand C, Jordan MA.
    Cancer Res; 2004 Jul 15; 64(14):4957-64. PubMed ID: 15256469
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Investigation of the mechanism and apoptotic pathway induced by 4β cinnamido linked podophyllotoxins against human lung cancer cells A549.
    Kamal A, Nayak VL, Bagul C, Vishnuvardhan MV, Mallareddy A.
    Apoptosis; 2015 Nov 15; 20(11):1518-29. PubMed ID: 26386574
    [Abstract] [Full Text] [Related]

  • 14. SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells.
    Langdon CG, Wiedemann N, Held MA, Mamillapalli R, Iyidogan P, Theodosakis N, Platt JT, Levy F, Vuagniaux G, Wang S, Bosenberg MW, Stern DF.
    Oncotarget; 2015 Nov 10; 6(35):37410-25. PubMed ID: 26485762
    [Abstract] [Full Text] [Related]

  • 15. Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells.
    Martinelli E, Troiani T, Morgillo F, Rodolico G, Vitagliano D, Morelli MP, Tuccillo C, Vecchione L, Capasso A, Orditura M, De Vita F, Eckhardt SG, Santoro M, Berrino L, Ciardiello F.
    Clin Cancer Res; 2010 Oct 15; 16(20):4990-5001. PubMed ID: 20810384
    [Abstract] [Full Text] [Related]

  • 16. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
    Oizumi S, Isobe H, Ogura S, Ishida T, Yamazaki K, Nishimura M, Kawakami Y, Dosaka-Akita H.
    Anticancer Res; 2002 Oct 15; 22(6C):4029-37. PubMed ID: 12553028
    [Abstract] [Full Text] [Related]

  • 17. The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells.
    Azijli K, van Roosmalen IA, Smit J, Pillai S, Fukushima M, de Jong S, Peters GJ, Bijnsdorp IV, Kruyt FA.
    Cancer Chemother Pharmacol; 2014 Jun 15; 73(6):1273-83. PubMed ID: 24744163
    [Abstract] [Full Text] [Related]

  • 18. Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells.
    Zhou Y, Pan DS, Shan S, Zhu JZ, Zhang K, Yue XP, Nie LP, Wan J, Lu XP, Zhang W, Ning ZQ.
    Biomed Pharmacother; 2014 May 15; 68(4):483-91. PubMed ID: 24721323
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
    Song J, Ko HS, Sohn EJ, Kim B, Kim JH, Kim HJ, Kim C, Kim JE, Kim SH.
    Bioorg Med Chem Lett; 2014 Feb 15; 24(4):1188-91. PubMed ID: 24461294
    [Abstract] [Full Text] [Related]

  • 20. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z, Zeng Q, Zhang B, Liu H, Wang W.
    Biochimie; 2014 Dec 15; 107 Pt B():257-62. PubMed ID: 25220870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.